Candel Therapeutics Inc

NASDAQ:CADL   4:00:00 PM EDT
1.58
+0.04 (+2.60%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)45.69M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.02 Million
Adjusted EPS-$0.18
See more estimates
10-Day MA$1.53
50-Day MA$1.51
200-Day MA$1.21
See more pivots

Candel Therapeutics Inc Stock, NASDAQ:CADL

117 Kendrick Street, Suite 450, Needham, Massachusetts 02494
United States of America
Phone: +1.617.916.5445
Number of Employees: 76

Description

Candel Therapeutics, Inc. is a late clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.